Like the funding deal executed today. Brings current cash up to $4.8M with access to another another $18M. "We believe AVR's technology could drastically change the landscape of the aortic valve replacement market. We have the highest confidence in Anteris' management to unlock that potential through 2021" Pricing was reasonable on the conversion price. AVR is fully funded through 2021/2022 now.
Like the funding deal executed today. Brings current cash up to...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.30 |
Change
0.000(0.00%) |
Mkt cap ! $351.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.30 | 247 | 2 |
View Market Depth
| Last trade - 08.16am 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable